4本のエピソード
New Scientist Colab Podcasts New Scientist
-
- 科学
Podcasts for the insatiably curious, produced by New Scientist in collaboration with carefully selected external parties.
Hosted on Acast. See acast.com/privacy for more information.
-
Industrial AI and the sustainability revolution - with Pina Schlombs from Siemens
Artificial Intelligence is revolutionising manufacturing and transforming the industrial world. From solving challenges thought unsolvable, to improving efficiency and sustainability, AI is a new type of industrial revolution that reduces energy usage and waste. And at its helm is global technology company Siemens.
Pina Schlombs is an expert on sustainability and AI at Siemens and in this episode she discusses:
A robot gripper showcasing the power of industrial AI to solve complex engineering problems in a way that reduces their environmental impact.How industrial copilots are transforming the way we programme machines and generate product designs.How the logistics and carbon footprints of supply routes are being optimised with industrial AI.And why she’s optimistic this technology will help us achieve our ambitious net-zero goals.
This is a New Scientist CoLab production, sponsored by Siemens.
Your host is Justin Mullins. Find out more at newscientist.com/podcasts
Hosted on Acast. See acast.com/privacy for more information. -
Transforming clinical trials: We meet Dr Melanie Ivarsson, from the global biotechnology company Moderna, to find out why she chose the UK for a billion-pound research and development program
As the UK transforms its ecosystem for clinical trials, the regulatory landscape is undergoing its biggest change in 20 years. In this third episode of this free New Scientist podcast, we meet Dr Melanie Ivarsson, from the global biotechnology company Moderna, to find out why she chose the UK for a billion-pound research and development program.
Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency
Hosted on Acast. See acast.com/privacy for more information. -
Transforming clinical trials: We meet Prof Andrea Manfrin whose team is responsible for driving change at the Medicines and Healthcare products Regulatory Agency
As the UK transforms its ecosystem for clinical trials, the regulatory landscape is undergoing its biggest change in 20 years. In this free New Scientist podcast, we meet Professor Andrea Manfrin whose team is responsible for driving this change at the Medicines and Healthcare products Regulatory Agency.
Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency
Hosted on Acast. See acast.com/privacy for more information. -
Transforming clinical trials: We ask James O'Shaughnessy how the UK independent review has influenced the reinvention of the clinical trials infrastructure
The UK has long been a world leader for clinical trials and life sciences research. But after losing ground post-COVID and post-Brexit, the country has begun to rethink the landscape for clinical trials. In this free New Scientist podcast, we meet the chair of the UK review into commercial clinical trials, James O'Shaughnessy, and ask how the independent review has influenced the reinvention of the clinical trials infrastructure for a new age of medicine.
Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency
Hosted on Acast. See acast.com/privacy for more information.